DNases Ligases RNA Polymerases Market

Recombinant enzymes are estimated to represent 51.0% of enzyme source demand in 2026, followed by direct sales at 47.0% within distribution channels and pharmaceutical and biotechnology companies at 43.0% among end users. Commercial demand depends on reproducible enzyme activity across validated nucleic-acid workflows, while storage sensitivity and lot variation can prolong qualification.